Date: Friday 17th March 2023
Time: 13:00-14:00 GMT
Speakers: Christine Fletcher (GSK), Christy Mazzarisi (Mersana) and Paul Frewer (AstraZeneca).
Who is this event intended for? Anyone interested in learning about or developing leadership skills in the modern day hybrid working world.
What is the benefit of attending? This session will cover the successes, challenges and changes needed by our leaders and managers in order to best support the changing workforce, whether that be in the office, remote working or a combination of the two.
Registration for this webinar is free, and is now open to Members of PSI and Non-Members. We'd love for you to join us!
To register for this event, please click here.
This PSI Lunch & Learn series focuses on career-related topics through a panel discussion, hosted by Claire Brittain & Chetan Mistry.
Upcoming session: In the upcoming event - "Modern Leaders: Remote not Distant" - we will be discussing the need for a conscious evolution of leadership styles as remote working becomes commonplace.
Whilst there has been a lot of debate on office-based vs. remote workers, there has been less discussion on what 'good' leadership looks like in the new working world. This panel discussion will explore how leaders in our industry have had to adapt, adjust and evolve in order to remain effective in their roles.
|
Speaker |
Biography |
|
|
Innovative and accomplished Quality Systems Professional with a broad background in Pharmaceutical and Laboratory sciences with over 17 years industry practice. Overall background includes building and leading global teams across functions in the biotech and pharmaceutical space. She is passionate about continuous improvement activities and consistently building quality into each area of our lives by providing coaching, mentoring and professional support to team members, employees, and many others across industries who want to develop their leadership skills. Chair of Women in Quality group for the American Society for Quality, where she supports building the female leadership pipeline and building the future of success across various industries (automotive, aerospace, manufacturing, technology, etc.) Advocate and Gala Committee Member for the Tourette’s Association of America, Advocate for Make-A-Wish NJ and Powershift Ambassador for Shark Tank’s Daymond John. |
|
|
Paul has been a statistician in the industry for over 25 years, working for Eli Lilly, GSK, Ipsen and AstraZeneca. His initial experiences were as a statistician on post-marketing studies and since then has slowly moved backwards through the phases to his current role in early clinical development.He has worked across most therapeutic areas and has specialized solely in oncology for the past 15 years. He joined AstraZeneca in 2012 and is now a Biometrics Team Leader in the Early Oncology Statistics team. He supports multiple different compounds in the oncology therapeutic area across many studies from Phase I up to Phase IIb. He has published on the AZ decision making framework and presented several times on the topic at conferences over the last few years. |
|
|
Chrissie is the Vice President of Speciality and Primary Care Statistics at GSK. She has worked in the Pharmaceutical Industry for over 30 years and has experience of developing and commercialising new medicines in a variety of clinical disease areas across all phases of clinical development. Chrissie is actively engaged in statistical societies, pharmaceutical trade associations and initiatives relating to the Pharmaceutical Industry such as driving innovation in clinical trials and sharing implementation experiences of the estimand framework. She is an advocate and champion for diversity, equity and inclusion where she supports a variety of Women Leadership programs. |
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This webinar brings together three bitesize complementary sessions to help PSI contributors create conference presentations and posters that communicate clearly and inclusively. Participants will explore how to refine their message, prepare materials effectively, and adopt practical habits that support confident, accessible delivery. A focused, supportive session designed to elevate every contribution.
Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry. This month’s session, “Graphics Basics,” will introduce the fundamentals of producing graphics using the ggplot2 package.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
Join our Health Technology Assessment (HTA) European Special Interest Group (ESIG) for a webinar on the strategic role of statisticians in the Joint Clinical Assessment (JCA). The introduction of the JCA marks a new era for evidence generation and market access in Europe. As HTA requirements become more harmonized and methodologically demanding, the role of statisticians has evolved far beyond data analysis. Today, statistical expertise is central to shaping clinical development strategies, designing robust comparative evidence, and ensuring that submissions withstand the scrutiny of EU-level assessors. In this webinar, we explore how statisticians contribute strategically to successful JCA outcomes.
A 90-minute webinar featuring two case studies from Bayer and Roche demonstrating how statisticians successfully integrated into AI programs, followed by interactive discussion on strategies for elevating statistical expertise in the AI era.
Join us for an insightful webinar where we explore practical strategies for applying the estimand framework in clinical study reporting. Drawing on real-world experiences and case studies, we will share recommendations to help you: • Understand the role of estimands in improving transparency and interpretation of trial results. • Navigate common challenges in implementing the framework during reporting. • Apply best practices to enhance regulatory submissions, webposting in public registries (clinicaltrials.gov/CTIS), and scientific publications. Whether you are involved in clinical trial design, data analysis, or regulatory submissions, this session will provide actionable guidance to realize the full potential of the estimand framework.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We are seeking an experienced and visionary Statistics Director to join our Team and lead strategic statistical innovation across GSK’s Vaccines and Infectious Disease portfolio.
We are currently seeking a Biostatistician II to join our diverse and dynamic team.
We are currently seeking a Pharmacometrician to join our diverse and dynamic team.
As a Principal Biostatistician, you will lead the statistical strategy and delivery for Phase I–III oncology trials.
As a Senior Biostatistician I at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of innovative treatments and therapies.
As a Statistical Scientist at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of innovative treatments and therapies.
We have an exciting opportunity for an Associate Director, Biostatistics to join a passionate team within Advanced Quantitative Sciences – Full Development.
: We have an exciting opportunity for an Associate Director (AD), Statistical Programming, to join a passionate team within Advanced Quantitative Sciences- Development.
We have an exciting opportunity for a Principal Statistical Programmer, to join a passionate team within Advanced Quantitative Sciences – Development.
We are in search of a Senior Principal Biostatistician to join a passionate team within Advanced Quantitative Sciences.
We have an exciting opportunity for a Senior Principal Statistical Programmer, to join a passionate team within Advanced Quantitative Sciences – Development.
We are seeking a highly skilled and proactive Clinical Development Safety Statistics Expert to join our Biometry Department and the Biometry Leadership Team based in Toulouse (31, Oncopole) or Boulogne (92).
Pierre Fabre Laboratories are hiring a highly skilled and experienced Lead Statistician – Real World Evidence (RWE) to join the Biometry Department, part of the Data Science & Biometry Department, based in Toulouse (Oncopôle) or Boulogne.
We are seeking a highly skilled and experienced Lead Statistician in Clinical Trials to join our Biometry Department based in Toulouse (31, Oncopole) or Boulogne (92).
We currently have openings for Senior Statisticians based in the UK to join our Employee Owned Biostatistics CRO, Plus-Project.
We have an opportunity for an experienced high level Senior or Principal Statistician to join us on a permanent basis.
We are looking for Senior Statistical Programmers in the UK to join Veramed, where you'll deliver high-impact programming solutions in an FSP-style capacity, while advancing your career in a supportive, growth-driven environment.
